Structure

Physi-Chem Properties

Molecular Weight:  476.2
Volume:  470.024
LogP:  2.679
LogD:  2.253
LogS:  -4.548
# Rotatable Bonds:  6
TPSA:  129.34
# H-Bond Aceptor:  9
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.517
Synthetic Accessibility Score:  4.919
Fsp3:  0.68
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.129
MDCK Permeability:  3.504686173982918e-05
Pgp-inhibitor:  0.993
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.497
20% Bioavailability (F20%):  0.196
30% Bioavailability (F30%):  0.942

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.471
Plasma Protein Binding (PPB):  71.89019012451172%
Volume Distribution (VD):  1.341
Pgp-substrate:  24.392370223999023%

ADMET: Metabolism

CYP1A2-inhibitor:  0.199
CYP1A2-substrate:  0.047
CYP2C19-inhibitor:  0.143
CYP2C19-substrate:  0.095
CYP2C9-inhibitor:  0.288
CYP2C9-substrate:  0.049
CYP2D6-inhibitor:  0.89
CYP2D6-substrate:  0.144
CYP3A4-inhibitor:  0.624
CYP3A4-substrate:  0.411

ADMET: Excretion

Clearance (CL):  2.714
Half-life (T1/2):  0.402

ADMET: Toxicity

hERG Blockers:  0.674
Human Hepatotoxicity (H-HT):  0.785
Drug-inuced Liver Injury (DILI):  0.84
AMES Toxicity:  0.073
Rat Oral Acute Toxicity:  0.817
Maximum Recommended Daily Dose:  0.257
Skin Sensitization:  0.227
Carcinogencity:  0.219
Eye Corrosion:  0.003
Eye Irritation:  0.009
Respiratory Toxicity:  0.974

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC270312

Natural Product ID:  NPC270312
Common Name*:   3-O-Acetylnorcaesalpinin A
IUPAC Name:   [(1R,2S,3S,4aR,6aR,11aS,11bS)-1,3-diacetyloxy-4a-hydroxy-4,4,11b-trimethyl-7-oxo-1,2,3,5,6,6a,11,11a-octahydronaphtho[2,1-f][1]benzofuran-2-yl] acetate
Synonyms:  
Standard InCHIKey:  SJZIFWGVHGVKAH-AVZLBZSXSA-N
Standard InCHI:  InChI=1S/C25H32O9/c1-12(26)32-20-21(33-13(2)27)23(4,5)25(30)9-7-15-17(24(25,6)22(20)34-14(3)28)11-18-16(19(15)29)8-10-31-18/h8,10,15,17,20-22,30H,7,9,11H2,1-6H3/t15-,17+,20+,21-,22+,24+,25-/m1/s1
SMILES:  CC(=O)O[C@H]1[C@H](C(C)(C)[C@@]2(CC[C@@H]3[C@H](Cc4c(cco4)C3=O)[C@@]2(C)[C@H]1OC(=O)C)O)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL465810
PubChem CID:   11248550
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001634] Naphthofurans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26402 Caesalpinia crista Species Fabaceae Eukaryota n.a. Indonesia n.a. PMID[15921414]
NPO26402 Caesalpinia crista Species Fabaceae Eukaryota n.a. seed kernel n.a. PMID[15921414]
NPO26402 Caesalpinia crista Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO26402 Caesalpinia crista Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 2000.0 nM PMID[505543]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC270312 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9871 High Similarity NPC56358
0.9557 High Similarity NPC121995
0.9548 High Similarity NPC81405
0.949 High Similarity NPC188649
0.949 High Similarity NPC68848
0.9487 High Similarity NPC140952
0.943 High Similarity NPC288602
0.943 High Similarity NPC88841
0.9427 High Similarity NPC287559
0.9423 High Similarity NPC195954
0.9367 High Similarity NPC18986
0.9359 High Similarity NPC41880
0.9308 High Similarity NPC285567
0.9299 High Similarity NPC88007
0.9202 High Similarity NPC294512
0.9187 High Similarity NPC283209
0.9177 High Similarity NPC194499
0.913 High Similarity NPC276735
0.9114 High Similarity NPC104736
0.9096 High Similarity NPC472665
0.908 High Similarity NPC296558
0.9074 High Similarity NPC86800
0.9057 High Similarity NPC304692
0.9038 High Similarity NPC212257
0.9036 High Similarity NPC176413
0.9036 High Similarity NPC56953
0.9012 High Similarity NPC472664
0.9006 High Similarity NPC472771
0.9 High Similarity NPC474611
0.8951 High Similarity NPC472773
0.8944 High Similarity NPC8389
0.8924 High Similarity NPC294511
0.8924 High Similarity NPC121615
0.8917 High Similarity NPC228842
0.8903 High Similarity NPC233763
0.8902 High Similarity NPC472775
0.8902 High Similarity NPC472774
0.8889 High Similarity NPC79571
0.8855 High Similarity NPC475237
0.8855 High Similarity NPC475641
0.8854 High Similarity NPC211625
0.8848 High Similarity NPC291742
0.8848 High Similarity NPC160651
0.8846 High Similarity NPC71821
0.8846 High Similarity NPC255414
0.8841 High Similarity NPC475779
0.8834 High Similarity NPC14499
0.8834 High Similarity NPC475039
0.8834 High Similarity NPC292389
0.8834 High Similarity NPC469338
0.8834 High Similarity NPC476035
0.882 High Similarity NPC167142
0.882 High Similarity NPC7059
0.882 High Similarity NPC472772
0.8812 High Similarity NPC264943
0.8788 High Similarity NPC473753
0.8788 High Similarity NPC473766
0.8788 High Similarity NPC173516
0.878 High Similarity NPC476857
0.878 High Similarity NPC469849
0.878 High Similarity NPC276551
0.878 High Similarity NPC470940
0.878 High Similarity NPC476856
0.878 High Similarity NPC476858
0.8773 High Similarity NPC329938
0.8773 High Similarity NPC82851
0.8773 High Similarity NPC200782
0.8773 High Similarity NPC263432
0.8735 High Similarity NPC471397
0.8734 High Similarity NPC125182
0.8734 High Similarity NPC69647
0.8727 High Similarity NPC277618
0.8727 High Similarity NPC470875
0.8727 High Similarity NPC308156
0.872 High Similarity NPC476197
0.872 High Similarity NPC477405
0.8712 High Similarity NPC25255
0.8696 High Similarity NPC75310
0.8696 High Similarity NPC476262
0.8696 High Similarity NPC469336
0.8688 High Similarity NPC476201
0.8675 High Similarity NPC476850
0.8675 High Similarity NPC476853
0.8675 High Similarity NPC472282
0.8675 High Similarity NPC476861
0.8667 High Similarity NPC476860
0.8662 High Similarity NPC62799
0.8659 High Similarity NPC69028
0.8659 High Similarity NPC470939
0.8659 High Similarity NPC193798
0.865 High Similarity NPC477403
0.8634 High Similarity NPC178932
0.8634 High Similarity NPC114880
0.8634 High Similarity NPC282445
0.8614 High Similarity NPC23387
0.8614 High Similarity NPC472141
0.8606 High Similarity NPC134254
0.8606 High Similarity NPC39986
0.8606 High Similarity NPC302369
0.8598 High Similarity NPC477402
0.8598 High Similarity NPC472653
0.8589 High Similarity NPC472778
0.8589 High Similarity NPC299038
0.8589 High Similarity NPC469847
0.8589 High Similarity NPC249021
0.8589 High Similarity NPC472776
0.8589 High Similarity NPC472777
0.8571 High Similarity NPC118086
0.8571 High Similarity NPC44602
0.8571 High Similarity NPC475777
0.8571 High Similarity NPC469503
0.8571 High Similarity NPC88593
0.8571 High Similarity NPC268905
0.8562 High Similarity NPC476122
0.8562 High Similarity NPC469335
0.8562 High Similarity NPC196864
0.8562 High Similarity NPC159927
0.8562 High Similarity NPC477404
0.8554 High Similarity NPC123088
0.8554 High Similarity NPC470182
0.8553 High Similarity NPC19747
0.8545 High Similarity NPC471166
0.8545 High Similarity NPC471167
0.8537 High Similarity NPC475226
0.8537 High Similarity NPC473368
0.8537 High Similarity NPC475967
0.8528 High Similarity NPC469485
0.8526 High Similarity NPC263337
0.8526 High Similarity NPC121158
0.8512 High Similarity NPC271235
0.8512 High Similarity NPC255787
0.8509 High Similarity NPC18135
0.8503 High Similarity NPC93172
0.8503 High Similarity NPC97574
0.8494 Intermediate Similarity NPC472139
0.8494 Intermediate Similarity NPC51568
0.8494 Intermediate Similarity NPC224394
0.8494 Intermediate Similarity NPC419
0.8494 Intermediate Similarity NPC663
0.8494 Intermediate Similarity NPC471168
0.8494 Intermediate Similarity NPC234660
0.8491 Intermediate Similarity NPC224418
0.8485 Intermediate Similarity NPC333139
0.8485 Intermediate Similarity NPC191828
0.8485 Intermediate Similarity NPC335761
0.8481 Intermediate Similarity NPC5676
0.8476 Intermediate Similarity NPC472283
0.8476 Intermediate Similarity NPC470118
0.8476 Intermediate Similarity NPC173544
0.8471 Intermediate Similarity NPC469848
0.8466 Intermediate Similarity NPC469850
0.8466 Intermediate Similarity NPC92979
0.8462 Intermediate Similarity NPC470995
0.8462 Intermediate Similarity NPC302392
0.8457 Intermediate Similarity NPC472672
0.8457 Intermediate Similarity NPC75906
0.8452 Intermediate Similarity NPC472764
0.8443 Intermediate Similarity NPC271657
0.8443 Intermediate Similarity NPC126984
0.8443 Intermediate Similarity NPC27541
0.8443 Intermediate Similarity NPC62692
0.8443 Intermediate Similarity NPC61967
0.8434 Intermediate Similarity NPC5079
0.8434 Intermediate Similarity NPC472668
0.8434 Intermediate Similarity NPC470792
0.8434 Intermediate Similarity NPC18347
0.8434 Intermediate Similarity NPC149896
0.8424 Intermediate Similarity NPC237155
0.8424 Intermediate Similarity NPC473473
0.8424 Intermediate Similarity NPC123153
0.8424 Intermediate Similarity NPC307383
0.8424 Intermediate Similarity NPC475295
0.8421 Intermediate Similarity NPC118128
0.8418 Intermediate Similarity NPC251865
0.8415 Intermediate Similarity NPC107646
0.8412 Intermediate Similarity NPC285227
0.8405 Intermediate Similarity NPC302054
0.8405 Intermediate Similarity NPC30222
0.8405 Intermediate Similarity NPC253201
0.8402 Intermediate Similarity NPC472765
0.8402 Intermediate Similarity NPC472766
0.84 Intermediate Similarity NPC105395
0.8385 Intermediate Similarity NPC472654
0.8383 Intermediate Similarity NPC469846
0.8383 Intermediate Similarity NPC472669
0.8373 Intermediate Similarity NPC472299
0.8373 Intermediate Similarity NPC475381
0.8372 Intermediate Similarity NPC167340
0.8364 Intermediate Similarity NPC261597
0.8364 Intermediate Similarity NPC286722
0.8364 Intermediate Similarity NPC36655
0.8364 Intermediate Similarity NPC1408
0.8364 Intermediate Similarity NPC246841
0.8364 Intermediate Similarity NPC197137
0.8364 Intermediate Similarity NPC45101
0.8354 Intermediate Similarity NPC44675
0.8354 Intermediate Similarity NPC281258
0.8354 Intermediate Similarity NPC179170
0.8354 Intermediate Similarity NPC35000
0.8354 Intermediate Similarity NPC214541

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC270312 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8882 High Similarity NPD8434 Phase 2
0.8485 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.8133 Intermediate Similarity NPD5760 Phase 2
0.8133 Intermediate Similarity NPD5761 Phase 2
0.7892 Intermediate Similarity NPD3226 Approved
0.7853 Intermediate Similarity NPD6765 Approved
0.7853 Intermediate Similarity NPD6764 Approved
0.7811 Intermediate Similarity NPD7819 Suspended
0.7771 Intermediate Similarity NPD7473 Discontinued
0.7706 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD7411 Suspended
0.7688 Intermediate Similarity NPD5494 Approved
0.768 Intermediate Similarity NPD6785 Approved
0.768 Intermediate Similarity NPD6784 Approved
0.7674 Intermediate Similarity NPD7075 Discontinued
0.7665 Intermediate Similarity NPD920 Approved
0.7661 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD1471 Phase 3
0.7654 Intermediate Similarity NPD6559 Discontinued
0.7633 Intermediate Similarity NPD6599 Discontinued
0.7622 Intermediate Similarity NPD4628 Phase 3
0.7614 Intermediate Similarity NPD8404 Phase 2
0.76 Intermediate Similarity NPD6232 Discontinued
0.7582 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7572 Intermediate Similarity NPD3749 Approved
0.7568 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD6801 Discontinued
0.7543 Intermediate Similarity NPD1247 Approved
0.7528 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD5844 Phase 1
0.7457 Intermediate Similarity NPD3817 Phase 2
0.7443 Intermediate Similarity NPD8127 Discontinued
0.744 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.743 Intermediate Similarity NPD3818 Discontinued
0.7429 Intermediate Similarity NPD919 Approved
0.7416 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD6799 Approved
0.7377 Intermediate Similarity NPD8313 Approved
0.7377 Intermediate Similarity NPD8312 Approved
0.736 Intermediate Similarity NPD3926 Phase 2
0.7356 Intermediate Similarity NPD5402 Approved
0.7349 Intermediate Similarity NPD2800 Approved
0.7345 Intermediate Similarity NPD6959 Discontinued
0.7341 Intermediate Similarity NPD1934 Approved
0.7337 Intermediate Similarity NPD2532 Approved
0.7337 Intermediate Similarity NPD2534 Approved
0.7337 Intermediate Similarity NPD2533 Approved
0.7333 Intermediate Similarity NPD2344 Approved
0.7333 Intermediate Similarity NPD2346 Discontinued
0.7326 Intermediate Similarity NPD4380 Phase 2
0.7321 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD2799 Discontinued
0.7314 Intermediate Similarity NPD3882 Suspended
0.7299 Intermediate Similarity NPD2801 Approved
0.7294 Intermediate Similarity NPD6273 Approved
0.7273 Intermediate Similarity NPD2796 Approved
0.7273 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD7458 Discontinued
0.7258 Intermediate Similarity NPD8150 Discontinued
0.7241 Intermediate Similarity NPD37 Approved
0.7235 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD6166 Phase 2
0.7222 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD4966 Approved
0.7216 Intermediate Similarity NPD4967 Phase 2
0.7216 Intermediate Similarity NPD4965 Approved
0.7216 Intermediate Similarity NPD7768 Phase 2
0.7207 Intermediate Similarity NPD6808 Phase 2
0.7202 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD1549 Phase 2
0.7179 Intermediate Similarity NPD7435 Discontinued
0.7169 Intermediate Similarity NPD1551 Phase 2
0.716 Intermediate Similarity NPD2313 Discontinued
0.716 Intermediate Similarity NPD2309 Approved
0.7158 Intermediate Similarity NPD7074 Phase 3
0.7151 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD5403 Approved
0.7151 Intermediate Similarity NPD8407 Phase 2
0.7143 Intermediate Similarity NPD3751 Discontinued
0.7143 Intermediate Similarity NPD7799 Discontinued
0.7143 Intermediate Similarity NPD1243 Approved
0.7135 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD6234 Discontinued
0.7135 Intermediate Similarity NPD5401 Approved
0.7126 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD7236 Approved
0.7104 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7104 Intermediate Similarity NPD7054 Approved
0.7083 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD8368 Discontinued
0.7066 Intermediate Similarity NPD6100 Approved
0.7066 Intermediate Similarity NPD6099 Approved
0.7066 Intermediate Similarity NPD2935 Discontinued
0.7065 Intermediate Similarity NPD7472 Approved
0.7062 Intermediate Similarity NPD8285 Discontinued
0.7056 Intermediate Similarity NPD7199 Phase 2
0.7048 Intermediate Similarity NPD7097 Phase 1
0.7037 Intermediate Similarity NPD6832 Phase 2
0.7027 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7026 Intermediate Similarity NPD6782 Approved
0.7026 Intermediate Similarity NPD6776 Approved
0.7026 Intermediate Similarity NPD6781 Approved
0.7026 Intermediate Similarity NPD6780 Approved
0.7026 Intermediate Similarity NPD6778 Approved
0.7026 Intermediate Similarity NPD6777 Approved
0.7026 Intermediate Similarity NPD6779 Approved
0.7017 Intermediate Similarity NPD3787 Discontinued
0.7017 Intermediate Similarity NPD7229 Phase 3
0.7011 Intermediate Similarity NPD7239 Suspended
0.7006 Intermediate Similarity NPD1465 Phase 2
0.7006 Intermediate Similarity NPD7033 Discontinued
0.7006 Intermediate Similarity NPD1510 Phase 2
0.7005 Intermediate Similarity NPD7497 Discontinued
0.7005 Intermediate Similarity NPD7696 Phase 3
0.7005 Intermediate Similarity NPD7698 Approved
0.7005 Intermediate Similarity NPD7697 Approved
0.7 Intermediate Similarity NPD3750 Approved
0.6989 Remote Similarity NPD7251 Discontinued
0.6988 Remote Similarity NPD6651 Approved
0.6978 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6977 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6977 Remote Similarity NPD1511 Approved
0.6971 Remote Similarity NPD5808 Clinical (unspecified phase)
0.697 Remote Similarity NPD7870 Phase 2
0.697 Remote Similarity NPD7871 Phase 2
0.6965 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6965 Remote Similarity NPD7874 Approved
0.6959 Remote Similarity NPD6190 Approved
0.6957 Remote Similarity NPD7228 Approved
0.6952 Remote Similarity NPD7808 Phase 3
0.6951 Remote Similarity NPD3764 Approved
0.6951 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6951 Remote Similarity NPD3268 Approved
0.6951 Remote Similarity NPD6859 Clinical (unspecified phase)
0.694 Remote Similarity NPD2403 Approved
0.6935 Remote Similarity NPD6797 Phase 2
0.6935 Remote Similarity NPD5953 Discontinued
0.6928 Remote Similarity NPD6355 Discontinued
0.6928 Remote Similarity NPD447 Suspended
0.6919 Remote Similarity NPD7286 Phase 2
0.6911 Remote Similarity NPD8360 Approved
0.6911 Remote Similarity NPD8435 Approved
0.6911 Remote Similarity NPD8361 Approved
0.6909 Remote Similarity NPD8032 Phase 2
0.6905 Remote Similarity NPD3748 Approved
0.6901 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6901 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6901 Remote Similarity NPD7003 Approved
0.6901 Remote Similarity NPD4110 Phase 3
0.6898 Remote Similarity NPD7685 Pre-registration
0.6897 Remote Similarity NPD1512 Approved
0.6897 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6886 Remote Similarity NPD1607 Approved
0.6875 Remote Similarity NPD1608 Approved
0.6867 Remote Similarity NPD1240 Approved
0.6866 Remote Similarity NPD7701 Phase 2
0.6847 Remote Similarity NPD7801 Approved
0.6832 Remote Similarity NPD8151 Discontinued
0.6831 Remote Similarity NPD5710 Approved
0.6831 Remote Similarity NPD5711 Approved
0.6816 Remote Similarity NPD8455 Phase 2
0.681 Remote Similarity NPD2798 Approved
0.6809 Remote Similarity NPD7240 Approved
0.6807 Remote Similarity NPD6233 Phase 2
0.6802 Remote Similarity NPD8166 Discontinued
0.68 Remote Similarity NPD8319 Approved
0.68 Remote Similarity NPD8320 Phase 1
0.6794 Remote Similarity NPD7907 Approved
0.6788 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6788 Remote Similarity NPD7095 Approved
0.6784 Remote Similarity NPD6823 Phase 2
0.677 Remote Similarity NPD3972 Approved
0.6769 Remote Similarity NPD6534 Approved
0.6769 Remote Similarity NPD6535 Approved
0.6768 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6766 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6766 Remote Similarity NPD4140 Approved
0.6765 Remote Similarity NPD7783 Phase 2
0.6765 Remote Similarity NPD7782 Clinical (unspecified phase)
0.676 Remote Similarity NPD6279 Approved
0.676 Remote Similarity NPD6280 Approved
0.6751 Remote Similarity NPD7700 Phase 2
0.6751 Remote Similarity NPD7699 Phase 2
0.6748 Remote Similarity NPD3266 Approved
0.6748 Remote Similarity NPD3267 Approved
0.6747 Remote Similarity NPD6798 Discontinued
0.6736 Remote Similarity NPD4287 Approved
0.6726 Remote Similarity NPD1933 Approved
0.6726 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6725 Remote Similarity NPD5763 Approved
0.6725 Remote Similarity NPD6003 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data